The Valley Desk

Clinical trial reportThe British journal of dermatologyPublished

Efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa-associated advanced/metastatic cutaneous squamous cell carcinoma

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Sidney Kimmel Medical College, Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
The British journal of dermatology
Published
Subject terms
Humans; Carcinoma, Squamous Cell; Skin Neoplasms; Epidermolysis Bullosa Dystrophica; Sulfones; Glycine; Cell Cycle Proteins; Proto-Oncogene Proteins; Antineoplastic Agents; Treatment Outcome; Quality of Life; Adult
PubMed ID
40439508
Added to directory
Source checked

Report a correction or request removal